These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34741035)

  • 1. Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.
    Ebrahimi-Nik H; Moussa M; Englander RP; Singhaviranon S; Michaux J; Pak H; Miyadera H; Corwin WL; Keller GLJ; Hagymasi AT; Shcheglova TV; Coukos G; Baker BM; Mandoiu II; Bassani-Sternberg M; Srivastava PK
    Nat Commun; 2021 Nov; 12(1):6423. PubMed ID: 34741035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding.
    Cale EM; Bazick HS; Rianprakaisang TA; Alam SM; Letvin NL
    J Immunol; 2011 Sep; 187(6):3300-13. PubMed ID: 21841125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting.
    Schmidt J; Smith AR; Magnin M; Racle J; Devlin JR; Bobisse S; Cesbron J; Bonnet V; Carmona SJ; Huber F; Ciriello G; Speiser DE; Bassani-Sternberg M; Coukos G; Baker BM; Harari A; Gfeller D
    Cell Rep Med; 2021 Feb; 2(2):100194. PubMed ID: 33665637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses.
    Shorter SK; Schnell FJ; McMaster SR; Pinelli DF; Andargachew R; Evavold BD
    PLoS One; 2016; 11(2):e0149582. PubMed ID: 26915099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
    Hardy LL; Wick DA; Webb JR
    J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides.
    Besser H; Yunger S; Merhavi-Shoham E; Cohen CJ; Louzoun Y
    J Immunother Cancer; 2019 May; 7(1):135. PubMed ID: 31118084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes.
    Trujillo JA; Gras S; Twist KA; Croft NP; Channappanavar R; Rossjohn J; Purcell AW; Perlman S
    J Immunol; 2014 Jun; 192(11):5245-56. PubMed ID: 24795457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
    Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI
    Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance.
    Rosendahl Huber SK; Luimstra JJ; van Beek J; Hoppes R; Jacobi RH; Hendriks M; Kapteijn K; Ouwerkerk C; Rodenko B; Ovaa H; de Jonge J
    PLoS One; 2016; 11(6):e0156462. PubMed ID: 27333291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of CD8+ T cells in advanced-stage tumors and delay of disease progression following secondary immunization against an immunorecessive epitope.
    Ryan CM; Schell TD
    J Immunol; 2006 Jul; 177(1):255-67. PubMed ID: 16785521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T Cell-Dependent Antitumor Activity In Vivo of a Mass Spectrometry-Identified Neoepitope despite Undetectable CD8+ Immunogenicity In Vitro.
    Gillig MA; Brennick CA; George MM; Balsbaugh JL; Shcheglova TV; Mandoiu II; Rosales T; Baker BM; Srivastava PK; Karandikar SH
    J Immunol; 2023 Dec; 211(12):1783-1791. PubMed ID: 37966257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells.
    Watson AM; Mylin LM; Thompson MM; Schell TD
    J Immunol; 2012 Dec; 189(12):5549-60. PubMed ID: 23175697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen.
    Zhou S; Song Y; Luo Y; Quinn B; Jiao Y; Long MD; Abrams SI; Lovell JF
    Cancer Res Commun; 2024 Apr; 4(4):958-969. PubMed ID: 38506662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space.
    Ogishi M; Yotsuyanagi H
    Front Immunol; 2019; 10():827. PubMed ID: 31057550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Recognition by CD8+ T Cells of Epitopes with Amino Acid Variations Outside Known MHC Anchor or T Cell Receptor Recognition Residues.
    Wilson KL; Xiang SD; Plebanski M
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term persistence of CD4(+) but rapid disappearance of CD8(+) T cells expressing an MHC class I-restricted TCR of nanomolar affinity.
    Engels B; Chervin AS; Sant AJ; Kranz DM; Schreiber H
    Mol Ther; 2012 Mar; 20(3):652-60. PubMed ID: 22233579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional Immune Escape during Chronic Simian Immunodeficiency Virus Infection.
    Gellerup DD; Balgeman AJ; Nelson CW; Ericsen AJ; Scarlotta M; Hughes AL; O'Connor SL
    J Virol; 2016 Jan; 90(1):545-52. PubMed ID: 26491171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.